Home > Research > Publications & Outputs > Paranoid psychosis due to flecainide toxicity i...

Research

Links

Text available via DOI:

Keywords

View graph of relations

Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain. / Bennett, Michael I.
In: Pain, Vol. 70, No. 1, 03.1997, p. 93-94.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Bennett, MI 1997, 'Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain.', Pain, vol. 70, no. 1, pp. 93-94. https://doi.org/10.1016/S0304-3959(96)03241-1

APA

Bennett, M. I. (1997). Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain. Pain, 70(1), 93-94. https://doi.org/10.1016/S0304-3959(96)03241-1

Vancouver

Bennett MI. Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain. Pain. 1997 Mar;70(1):93-94. doi: 10.1016/S0304-3959(96)03241-1

Author

Bennett, Michael I. / Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain. In: Pain. 1997 ; Vol. 70, No. 1. pp. 93-94.

Bibtex

@article{fd60c0ea3a0c4f9cbb107cdf290023cf,
title = "Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain.",
abstract = "Flecainide was used to treat malignant neuropathic pain but despite using therapeutic doses, toxicity occurred resulting in paranoid psychosis. Monitoring of flecainide levels in vulnerable populations is suggested to guide prescribing.",
keywords = "Flecainide, Neuropathic pain, Psychosis, Serum monitoring neuropathy, pain, psychosis, flecainide",
author = "Bennett, {Michael I.}",
year = "1997",
month = mar,
doi = "10.1016/S0304-3959(96)03241-1",
language = "English",
volume = "70",
pages = "93--94",
journal = "Pain",
issn = "1872-6623",
publisher = "Elsevier",
number = "1",

}

RIS

TY - JOUR

T1 - Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain.

AU - Bennett, Michael I.

PY - 1997/3

Y1 - 1997/3

N2 - Flecainide was used to treat malignant neuropathic pain but despite using therapeutic doses, toxicity occurred resulting in paranoid psychosis. Monitoring of flecainide levels in vulnerable populations is suggested to guide prescribing.

AB - Flecainide was used to treat malignant neuropathic pain but despite using therapeutic doses, toxicity occurred resulting in paranoid psychosis. Monitoring of flecainide levels in vulnerable populations is suggested to guide prescribing.

KW - Flecainide

KW - Neuropathic pain

KW - Psychosis

KW - Serum monitoring neuropathy

KW - pain

KW - psychosis

KW - flecainide

U2 - 10.1016/S0304-3959(96)03241-1

DO - 10.1016/S0304-3959(96)03241-1

M3 - Journal article

VL - 70

SP - 93

EP - 94

JO - Pain

JF - Pain

SN - 1872-6623

IS - 1

ER -